I. Introduction
Fine-needle aspiration cytology (FNAC) is part of the triple assessment for the diagnosis of PBLs. It is an established, highly accurate method for diagnosing breast cancer (BCA) and has given rise to a reduction in the number of excision biopsies for benign breast disease 
II. Material and Methods
The present study was performed on 66 patients complaining of palpable breast lumps (PBLs) in a period of 3 years through November 2010 to October 2013. The attending patients were examined clinically in the surgical outpatient clinic, Arar central Hospital, KSA. Fine needle aspiration cytology was performed for all these patients under the supervision of the consultant surgeon. The procedure of aspiration was done by the use of 25-gauge syringes under ultrasongraphic guided techniques. The nodule (s) to be aspirated was/were identified; the overlying skin is cleansed with alcohol. After withdrawal of the syringe, one drop of aspirated material is forced into each of several labeled microscopic slides with the patient' name and hospital number. Frequently, 8 to 10 slides were used, as well as from 2 to 4 aspirates were performed for accurate cytological evaluation (Oertal 1996). The obtained material is immediately immersed in absolute alcohol for fixation which was sent for the department of pathology for slides preparation. Following the cytological examination, all suspicious, malignant and inadequate cases were subjected to other invasive manoeuvers as core needle biopsy (CNB).Then the obtained tissue is fixed in 10% neutral puffered-formalin (Gattsuo et al., 2010). The smear slides were stained with Hematoxylin and Eosin (H&E) stains, as well as air dried smears are subjected to DiffQuik for immediate evaluation (Ariga et al., 2002) . The histological slides were prepared from the tissue specimens for paraffin-embedded formalin-fixed blocks then stained with H&E. All slides were evaluated by 2 experienced pathologists. All the examined FNAC cases were categorized according to standardized diagnostic categories in the form of 5 standard options includes: inadequate/insufficient, benign, atypical/indeterminate, suspicious of malignancy and malignant(National Breast Cancer Centre 2004). The adequacy of FNAC is dependent on multiple factors that include nature of the lesion, the available technology, and the experience and preference of the operator (Zakhour and Wells 1999). The smear is considered inadequate if there is hypocellularity, aspiration or smearing or staining errors (Zakhour and Wells 1999).
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Statistical analysis
The statistical analysis was undertaken using SPSS computer software (SPSS version 16 Microsoft windows). Z test was used for the comparison between two proportions. Results were considered to be statistically significant at p < 0.05.
III. Results
Cytologically, the inflammatory lesions are seen in 7 out of all cases (10.6%) (Figure 1 ), benign FNACs cases representing the commonest lesions, that are found in 37 cases (56.1%) (Figure 2 ), highly suspicious lesions are encountered in 6 cases (9.1%) (Figure 3 ), whereas malignant FNACs are detected in 7 (10.6%) (Figure 4) , and the unsatisfactory cases are representing 9 cases (13.6%) ( Table 1 ). Histologically, invasive duct carcinoma is the major subtype and representing 13 out of the 18 cases followed by mucinous carcinoma that encompassing 3 cases, whereas invasive lobular carcinoma is seen in 2 cases ( Table 3) . IDCa; invasive duct carcinoma, ILCa; invasive lobular carcinoma
In concern to the cyto-histopathological correlation among the benign lesions, fibroadenoma represents the major category that is seen in 29 out of all benign cases (60.4%), fibrocystic changes seen in 13 cases (27%), intraductal papilloma in 2 cases (4.2%), chronic abscess in 2 cases (4.2%), and mastopathy found in 2 cases (4.2%) ( Table 4 ). 
IV. Discussion
Despite the evidence of FNAC's value in diagnosis as has been previously reported, in recent years, its use in the diagnosis of breast lesions has declined in many health services providers. Cytologically this study revealed inflammatory lesion of the breast observed in 7 cases (10.6%), benign lesions detected in 37 cases (56.1%) which representing the commonest lesions, highly suspicious lesions in 6 cases (9.1%), malignancy in 7 cases (10.6%), and the unsatisfactory cases are found in 9 cases (13.6%). A study performed in Egypt on 246 patients found that benign lesions were in near to suspicious FNACs and were detected in 31 cases for benign (12.5%) and 28 for atypical / suspicious (11.4%) whereas, 162 were malignant (65.7%) that were representing the majority of cases (Abdel-Hadi et al., 2010) .
In this study 9 cases are in the category of unsatisfactory FNACs and is mainly due to marked hypocellularity, yet histologically 3 cases among them are malignant. The limitations of FNACs interpretation are mainly due to poor cellularity of mammary tumors with fibrotic stroma, poor preservation and difficulty in cytological differentiation of atypical benign lesions and well-differentiated malignant neoplasms Histopathologically fibroadenoma representing the major category that is seen in 29 out of all benign breast lesions (60.4%), fibrocystic changes (FCC) in 13 cases (27%), intraductal papilloma in 2 cases (4.2%), chronic abscess in 2 cases (4.2%), and mastopathy found in 2 cases (4.2%). In reviewing the literature, The bulk of breast FNAC diagnoses are benign, accounting for 24-77.5% of cases followed by FCC which showing a spectrum of histological features in which cystic changes represent a common finding (Mendoza et al., 2011) .In the same theme fibroadenoma is the most solid breast lesions and its diagnosis is highly accurate and a study reported79.3% predictive value out of 362 fibroadenoma aspirates with most diagnostic errors occurring in the older age group in addition to this, multiple fibroadenomas are seen in 15 to 20% of FNAC cases(LopezFerreret al., (1999); Zakhour and Wells 1999).
In this study core needle biopsy (CNB) was performed for all malignant, suspicious, benign, and the unsatisfactory cases that revealed invasive duct carcinoma (IDCa) is the major subtype of malignant cases and was representing 13 cases followed by mucinous carcinoma that encompassing 3 cases, whereas invasive lobular carcinoma is seen in 2 cases. A study performed on 200 patients with palpable breast lumps reported out of 65 benign FNAC cases, 5 cases were found malignant on histopathology, out of 5 suspicious cases on cytology, 3 cases were found malignant on histopathology, and all malignant FNACs cases were proved on histology as cancer in agreement with our findings (Ahmed et al., 2009) .
Although some authors consider that FNAC might be abandoned in favor of CNB (Litherland 2001;  Shannon et al., 2001) , the opinion that CNB does not replace FNAC as a first-line diagnostic modality for a breast lesion is evidenced by that CNB is not able to establish the diagnosis of malignancy revealed by FNAC in many results as Barra Adeet al., (2008) reported CNB was not able to establish the diagnosis for malignancy revealed by FNAC in 14 cases. Like FNAC, the accuracy of CNB in diagnosing breast cancer also varies in the literature. Dillon et al., (2005) reported false negative rates ranging from 0 to 12% for ultrasound guided CNB. Comparisons of sensitivity and specificity rates between FNAC and CNB have on occasion found that FNA has a higher accuracy rate in diagnosing breast cancers. Ballo and Sneige (1996) reported sensitivity and specificity of 97.5% and 100%, respectively, in FNA compared with 90% and 100%, respectively in CNB. Also they reported that sampling errors were the only cause of false-negative diagnoses with CNB.
